Company identity
Company number NI603247
Company profile
UK company NI603247, incorporated on 25 May 2010.
Home - Cirdan
Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
Company number NI603247
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
SH01 | Transaction MzUzNjk0MTM3N2FkaXF6a2N4
Published 04 Aug 2026 10:57
Company registered at Companies House
1 Dec 2021 to 30 Nov 2026
The Smart Nano-Manufacturing Corridor (SNMC) will bring together organisations from across Northern Ireland, using local strengths in Smart and Nano-Manufacturing to create a consortium with over 2000 jobs, providing value add of £220m to the local economy and increasing skill levels in local communities. Companies in Northern Ireland will get access to n...
1 Jan 2021 to 31 Jul 2021
Due to the global pandemic surrounding COVID-19, there is an increased demand for testing and added complications to the collection of test specimens. We are proposing an innovative solution to ensure the collection of test samples does not become the bottleneck. The collection of laboratory test specimens is in danger of becoming a bottleneck for the fol...
1 Feb 2019 to 31 Jul 2021
To enhance Pathology Medical device products with clinical expert intelligence derived from an embedded Deep learning system.
1 Nov 2015 to 31 Oct 2017
To develop a cloud based Platform as a Service (SC Cloud) to enable organisations to link their old world IT to the new world, by connecting disparate data sources together and making them available to modern web software and applications
1 Jan 2013 to 30 Jun 2016
To develop techniques in differentiating normal from abnormal cells by their surface properties for the early detection of cancer cells using advanced automated systems.
1 Dec 2011 to 30 Jun 2014
To develop enhanced sensor arrays for the detection of X-rays and Near Infrared using nanostructuring processes on a wafer scale.